Clinical Trials Browser

Phase 1 × nimotuzumab × Genitourinary × Clear all

NCT07053735 2025-07-08

An Exploratory Clinical Study of Nimotuzumab in Bladder - Sparing Chemoradiotherapy for Muscle - Invasive Bladder Cancer

Phase 1 Not yet recruiting

Urinary Bladder Neoplasms, Neoplasms